Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/... by Andrey I. Bakulev, Alexey V. Samtsov, Evgeny V. Sokolovskiy, Muza M. Kokhan, Marianna M. Khobeish, Vladislav R. Khairutdinov, Arfenya E. Karamova, Olga U. Olisova, Dmitry V. Ignatiev, Aleksandra N. Nikiforova, Antonina V. Artemeva, Arina V. Zinkina-Orikhan

Connect to this object online.